All News

Results from a phase 3 study and post-hoc analysis highlight the use of galcanezumab-gnlm (Emgality, Eli Lilly) for the treatment of episodic cluster headache and migraine.

The FDA has granted an accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of eligible patients aged 12 years and older with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer (mCRC).

The updated labeling will strengthen warnings for mental health adverse effects and risks related to hypoglycemia.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

New research identified predictors of long-term survival and health-related quality of life in patients with newly diagnosed multiple myeloma.

Information regarding the opioid crisis, lofexidine hydrochloride versus clonidine, and clinical pearls that pharmacists should know about.

A recent systematic review has shed light on increased glucose intake in the modern diet and the effects on mechanisms in the body.

The US Food and Drug Administration (FDA) has granted the US Department of Defense (DoD) an emergency use authorization (EUA) of freeze-dried plasma product (FDP) that is made in France.

Patients on atypical antipsychotics have 3 to 5 times greater risk of type 2 diabetes than others.

Two commonly used agents for the treatment of diarrhea are now being abused to obtain opioid-like highs.

Coffee drinkers with genetic polymorphisms may not need to be concerned with their coffee consumption based on new research.

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.

In the phase 3 PALOMA-3 trial, Pfizer’s palbociclib (Ibrance) narrowly missed reaching its secondary endpoint of overall survival (OS), according to a press release.

The PALOMA-3 trial evaluated palbociclib (Ibrance) in combination with fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis and identifies HIV coinfection in individuals in Western countries as a key risk factor.

A new, inexpensive diagnostic test can help identify patients who require immediate treatment for hepatitis B virus across Africa.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Naturally produced melatonin tends to decrease with advancing age, so supplementation is a potential intervention for metabolic syndrome.

Do you ever fear that you are growing complacent, and unprepared for any kind of change?

Pharmacists should ask themselves, is what got you where you are today going to get you where you want to go?

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis, and identifies HIV coinfection in individuals in Western countries as a key risk factor.

Prescription Verification is a critical step in the filling process. We should talk about it more with our students and colleagues.

Multiple sclerosis risk increased significantly in individuals with occupational exposure to organic solvents.

Researchers have developed a laser-sonic scanner with the ability to detect tumors in as little as 15 seconds.

Positive topline results from Study 201, a phase 2 study of BAN2401, an investigational Alzheimer Disease (AD) therapy, have been announced by Eisai Co. and Biogen.

New study results indicate that an experimental mosaic HIV vaccine may have the potential to protect against a wide-range of global HIV strains.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.